[Endocrine and neuroendocrine tumors].
Riss P, Scheuba K, Strobel O.
Chirurg. 2021 Nov;92(11):996-1002. doi: 10.1007/s00104-021-01512-8. Epub 2021 Oct 7.
[Update on endocrine hypertension].
Lechner B, Heinrich D, Nölting S, Osswald-Kopp A, Rubinstein G, Sauerbeck J, Beuschlein F, Reincke M.
Internist (Berl). 2018 Nov;59(11):1163-1179. doi: 10.1007/s00108-018-0505-3.
Immunohistochemical Biomarkers in Thyroid Pathology.
Baloch Z, Mete O, Asa SL.
Endocr Pathol. 2018 Jun;29(2):91-112. doi: 10.1007/s12022-018-9532-9.
The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma.
Samsudin I, Page MM, Hoad K, Chubb P, Gillett M, Glendenning P, Vasikaran S.
Ann Clin Biochem. 2018 Nov;55(6):679-684. doi: 10.1177/0004563218774590. Epub 2018 May 2.
Pediatric malignant pheochromocytoma.
Ein SH, Weitzman S, Thorner P, Seagram CG, Filler RM.
J Pediatr Surg. 1994 Sep;29(9):1197-201. doi: 10.1016/0022-3468(94)90799-4.
Local Tumor Behavior Associated With Survival Among Patients With Paraganglioma of the Head and Neck.
Harley RJ, Lee JH, Ostrander BT, Finegersh A, Pham TB, Tawfik KO, Ren Y, Faraji F, Friedman RA.
OTO Open. 2022 Mar 31;6(1):2473974X221086872. doi: 10.1177/2473974X221086872. eCollection 2022 Jan-Mar.
[Diagnosis of pheochromocytoma and paraganglioma: the clonidine suppression test in patients with borderline elevations of plasma free normetanephrine].
Därr R, Lenders JW, Stange K, Kindel B, Hofbauer LC, Bornstein SR, Eisenhofer G.
Dtsch Med Wochenschr. 2013 Jan;138(3):76-81. doi: 10.1055/s-0032-1327395. Epub 2013 Jan 8.
Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy.
Quint LE, Glazer GM, Francis IR, Shapiro B, Chenevert TL.
Radiology. 1987 Oct;165(1):89-93. doi: 10.1148/radiology.165.1.3628794.
A review of the management of positive biochemical screening for phaeochromocytoma and paraganglioma: a salutary tale.
Garrahy A, Casey R, Wall D, Bell M, O'Shea PM.
Int J Clin Pract. 2015 Jul;69(7):802-9. doi: 10.1111/ijcp.12612. Epub 2015 Feb 4.
Adrenal incidentaloma, borderline elevations of urine or plasma metanephrine levels, and the "subclinical" pheochromocytoma.
Lee JA, Zarnegar R, Shen WT, Kebebew E, Clark OH, Duh QY.
Arch Surg. 2007 Sep;142(9):870-3; discussion 73-4. doi: 10.1001/archsurg.142.9.870.
